Allosteric modulation of the 5-HT3 receptor

Current Opinion in Pharmacology

Volumn 11, Issue 1, 2011, Pages 75-80

  Davies, Paul A ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANESTHETIC GAS; ANTIDEPRESSANT AGENT; BARBITURIC ACID DERIVATIVE; CANNABINOID; CLOZAPINE; DOXEPIN; ETOMIDATE; FLUOXETINE; FLUPENTIXOL; FLUPHENAZINE; HALOPERIDOL; HALOTHANE; IMIPRAMINE; INTRAVENOUS ANESTHETIC AGENT; IPRONIAZID; KETAMINE; LEVOMEPROMAZINE; NEUROLEPTIC AGENT; NORFLUOXETINE; ONDANSETRON; PHENELZINE; PROPOFOL; REBOXETINE; SEROTONIN 3 ANTAGONIST; SEROTONIN 3 RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SEVOFLURANE; THIORIDAZINE; UNINDEXED DRUG;

ANXIETY; ARTICLE; BINDING SITE; CARDIOVASCULAR FUNCTION; DEPRESSION; DNA POLYMORPHISM; DRUG POTENCY; GASTROINTESTINAL TRACT FUNCTION; HUMAN; INFLAMMATION; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; RECEPTOR BINDING; SUBSTANCE ABUSE; VOMITING;

EID: 79953673851     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2011.01.010     Document Type: Review

References (44)

1. 2+ J Biol Chem 278 2003 712 717 (Pubitemid 36790740)
2. 3 receptors covering genetics, pathology, and pharmacology. It contains an updated review of competitve antagonists.
3. A.J. Thompson, and S.C. Lummis The 5-HT3 receptor as a therapeutic target Expert Opin Ther Targets 11 2007 527 540
4. M. Koshizaki, M. Kawamata, S.G. Shimada, Y. Saito, and J.G. Collins 5-HT3 receptors partially mediate halothane depression of spinal dorsal horn sensory neurons Anesth Analg 96 2003 1027 1031 (Pubitemid 36359036)
5. C.C. Apfel, P. Kranke, M.H. Katz, C. Goepfert, T. Papenfuss, S. Rauch, R. Heineck, C.A. Greim, and N. Roewer Volatile anaesthetics may be the main cause of early but not delayed postoperative vomiting: a randomized controlled trial of factorial design Br J Anaesth 88 2002 659 668 (Pubitemid 34498594)
6. R.J. Stevens, D. Rusch, P.A. Davies, and D.E. Raines Molecular properties important for inhaled anesthetic action on human 5-HT3A receptors Anesth Analg 100 2005 1696 1703 (Pubitemid 40712724)
7. R. Stevens, D. Rusch, K. Solt, D.E. Raines, and P.A. Davies Modulation of human 5-hydroxytryptamine type 3AB receptors by volatile anesthetics and n-alcohols J Pharmacol Exp Ther 314 2005 338 345 (Pubitemid 41058271)
8. V. Hayrapetyan, M. Jenschke, G.H. Dillon, and T.K. Machu Co-expression of the 5-HT(3B) subunit with the 5-HT(3A) receptor reduces alcohol sensitivity Brain Res Mol Brain Res 142 2005 146 150 (Pubitemid 41681282)
9. K. Solt, R.J. Stevens, P.A. Davies, and D.E. Raines General anesthetic-induced channel gating enhancement of 5-hydroxytryptamine type 3 receptors depends on receptor subunit composition J Pharmacol Exp Ther 315 2005 771 776 (Pubitemid 41500743)
10. D. Rusch, B. Musset, H. Wulf, A. Schuster, and D.E. Raines Subunit-dependent modulation of the 5-hydroxytryptamine type 3 receptor open-close equilibrium by n-alcohols J Pharmacol Exp Ther 321 2007 1069 1074 (Pubitemid 46762712)
11. S.P. Kelley, J.I. Dunlop, E.F. Kirkness, J.J. Lambert, and J.A. Peters A cytoplasmic region determines single-channel conductance in 5-HT3 receptors Nature 424 2003 321 324 (Pubitemid 36899374)
12. T.G. Hales, J.I. Dunlop, T.Z. Deeb, J.E. Carland, S.P. Kelley, J.J. Lambert, and J.A. Peters Common determinants of single channel conductance within the large cytoplasmic loop of 5-hydroxytryptamine type 3 and alpha4beta2 nicotinic acetylcholine receptors J Biol Chem 281 2006 8062 8071 (Pubitemid 43847424)
13. 3A receptors at a single channel level.
14. Q. Zhou, T.A. Verdoorn, and D.M. Lovinger Alcohols potentiate the function of 5-HT3 receptor-channels on NCB-20 neuroblastoma cells by favouring and stabilizing the open channel state J Physiol 507 1998 335 352 (Pubitemid 28135188)
15. X.Q. Hu, H. Sun, R.W. Peoples, R. Hong, and L. Zhang An interaction involving an arginine residue in the cytoplasmic domain of the 5-HT3A receptor contributes to receptor desensitization mechanism J Biol Chem 281 2006 21781 21788 (Pubitemid 44181882)
16. M. Barann, I. Linden, S. Witten, and B.W. Urban Molecular actions of propofol on human 5-HT3A receptors: enhancement as well as inhibition by closely related phenol derivatives Anesth Analg 106 2008 846 857 (Pubitemid 351301405)
17. D. Rusch, H.A. Braun, H. Wulf, A. Schuster, and D.E. Raines Inhibition of human 5-HT(3A) and 5-HT(3AB) receptors by etomidate, propofol and pentobarbital Eur J Pharmacol 573 2007 60 64 (Pubitemid 47464221)
18. I.S. Grant, W.S. Nimmo, L.R. McNicol, and J.A. Clements Ketamine disposition in children and adults Br J Anaesth 55 1983 1107 1111 (Pubitemid 14244442)
19. J.A. Peters, H.M. Malone, and J.J. Lambert Ketamine potentiates 5-HT3 receptor-mediated currents in rabbit nodose ganglion neurones Br J Pharmacol 103 1991 1623 1625
20. T. Yamakura, L.E. Chavez-Noriega, and R.A. Harris Subunit-dependent inhibition of human neuronal nicotinic acetylcholine receptors and other ligand-gated ion channels by dissociative anesthetics ketamine and dizocilpine Anesthesiology 92 2000 1144 1153 (Pubitemid 30180992)
21. P. Fan Effects of antidepressants on the inward current mediated by 5-HT3 receptors in rat nodose ganglion neurones Br J Pharmacol 112 1994 741 744 (Pubitemid 24199076)
22. J.S. Choi, B.H. Choi, H.S. Ahn, M.J. Kim, D.J. Rhie, S.H. Yoon, D.S. Min, Y.H. Jo, M.S. Kim, and K.W. Sung Mechanism of block by fluoxetine of 5-hydroxytryptamine3 (5-HT3)-mediated currents in NCB-20 neuroblastoma cells Biochem Pharmacol 66 2003 2125 2132 (Pubitemid 37377858)
23. F. Gumilar, and C. Bouzat Tricyclic antidepressants inhibit homomeric Cys-loop receptors by acting at different conformational states Eur J Pharmacol 584 2008 30 39 This study used the high conducting 5-HT3A subunit mutant to demonstrate that tricyclic antidepressants inhibit through both open and closed states. The study also examined the block at a single-channel level.
24. G. Rammes, B. Eisensamer, U. Ferrari, M. Shapa, G. Gimpl, K. Gilling, C. Parsons, K. Riering, G. Hapfelmeier, and B. Bondy Antipsychotic drugs antagonize human serotonin type 3 receptor currents in a noncompetitive manner Mol Psychiatry 9 2004 846 858 818 (Pubitemid 39273534)
25. B. Eisensamer, M. Uhr, S. Meyr, G. Gimpl, T. Deiml, G. Rammes, J.J. Lambert, W. Zieglgansberger, F. Holsboer, and R. Rupprecht Antidepressants and antipsychotic drugs colocalize with 5-HT3 receptors in raft-like domains J Neurosci 25 2005 10198 10206 (Pubitemid 41636216)
26. C. Nothdurfter, S. Tanasic, B. Di Benedetto, G. Rammes, E.M. Wagner, T. Kirmeier, V. Ganal, J.S. Kessler, T. Rein, and F. Holsboer Impact of lipid raft integrity on 5-HT3 receptor function and its modulation by antidepressants Neuropsychopharmacology 35 2010 1510 1519
27. R.G. Pertwee Emerging strategies for exploiting cannabinoid receptor agonists as medicines Br J Pharmacol 156 2009 397 411
28. M. Barann, G. Molderings, M. Bruss, H. Bonisch, B.W. Urban, and M. Gothert Direct inhibition by cannabinoids of human 5-HT3A receptors: probable involvement of an allosteric modulatory site Br J Pharmacol 137 2002 589 596 (Pubitemid 35333084)
29. W. Xiong, M. Hosoi, B.N. Koo, and L. Zhang Anandamide inhibition of 5-HT3A receptors varies with receptor density and desensitization Mol Pharmacol 73 2008 314 322 (Pubitemid 351159203)
30. 3 receptors show useful therapeutic potential. (Pubitemid 350005116)
31. K. Ueta, T. Suzuki, M. Sugimoto, I. Uchida, and T. Mashimo Local anesthetics have different mechanisms and sites of action at recombinant 5-HT3 receptors Reg Anesth Pain Med 32 2007 462 470 (Pubitemid 350116661)
32. M. Wittmann, I. Peters, T. Schaaf, H.C. Wartenberg, S. Wirz, J. Nadstawek, B.W. Urban, and M. Barann The effects of morphine on human 5-HT3A receptors Anesth Analg 103 2006 747 752 (Pubitemid 44542933)
33. M. Wittmann, T. Schaaf, I. Peters, S. Wirz, B.W. Urban, and M. Barann The effects of fentanyl-like opioids and hydromorphone on human 5-HT3A receptors Anesth Analg 107 2008 107 112
34. 3 receptor pharmacology.
35. K. Solt, D. Ruesch, S.A. Forman, P.A. Davies, and D.E. Raines Differential effects of serotonin and dopamine on human 5-HT3A receptor kinetics: interpretation within an allosteric kinetic model J Neurosci 27 2007 13151 13160 (Pubitemid 350220480)
36. K. Krzywkowski, P.A. Davies, P.L. Feinberg-Zadek, H. Brauner-Osborne, and A.A. Jensen High-frequency HTR3B variant associated with major depression dramatically augments the signaling of the human 5-HT3AB receptor Proc Natl Acad Sci U S A 105 2008 722 727 (Pubitemid 351171775)
37. M. Kato, T. Fukuda, M. Wakeno, K. Fukuda, G. Okugawa, Y. Ikenaga, M. Yamashita, Y. Takekita, K. Nobuhara, and J. Azuma Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese patients Neuropsychobiology 53 2006 186 195 (Pubitemid 44252779)
38. T. Sugai, Y. Suzuki, K. Sawamura, N. Fukui, Y. Inoue, and T. Someya The effect of 5-hydroxytryptamine 3A and 3B receptor genes on nausea induced by paroxetine Pharmacogenom J 6 2006 351 356 (Pubitemid 44480155)
39. B. Gu, L. Wang, A.P. Zhang, G. Ma, X.Z. Zhao, H.F. Li, G.Y. Feng, L. He, and Q.H. Xing Association between a polymorphism of the HTR3A gene and therapeutic response to risperidone treatment in drug-naive Chinese schizophrenia patients Pharmacogenet Genomics 18 2008 721 727
40. G. Rammes, C. Hosp, B. Eisensamer, S. Tanasic, C. Nothdurfter, W. Zieglgansberger, and R. Rupprecht Identification of a domain which affects kinetics and antagonistic potency of clozapine at 5-HT3 receptors PLoS ONE 4 2009 e6715
41. X. Ji, N. Takahashi, A. Branko, R. Ishihara, T. Nagai, A. Mouri, S. Saito, N. Maeno, T. Inada, and N. Ozaki An association between serotonin receptor 3B gene (HTR3B) and treatment-resistant schizophrenia (TRS) in a Japanese population Nagoya J Med Sci 70 2008 11 17
42. X. Ji, N. Takahashi, S. Saito, R. Ishihara, N. Maeno, T. Inada, and N. Ozaki Relationship between three serotonin receptor subtypes (HTR3A, HTR2A and HTR4) and treatment-resistant schizophrenia in the Japanese population Neurosci Lett 435 2008 95 98
43. C. Meineke, M.V. Tzvetkov, K. Bokelmann, E. Oetjen, K. Hirsch-Ernst, R. Kaiser, and J. Brockmoller Functional characterization of a -100-102delAAG deletion-insertion polymorphism in the promoter region of the HTR3B gene Pharmacogenet Genomics 18 2008 219 230
44. 3 receptors due to the lack of genes encoding these subunits.